点击阅读原文，即可报名参会！ 太科技4月28日在电话会议上表示，2025年公司目前要重点推进的产能建设计划具体是在马来西亚建设年产5万吨锂电池负极材料项目（马来 西亚项目）和山西省晋中市昔阳县建设年产20万吨锂离子电池负极材料一体化项目（即山西四期），上述项目预计均将在2025年第三季度开 始建设。 鉴于当前形势，为进一步扩展海外客户和海外市场，公司将进一步努力，全力推进 马来西亚项目的建设，预计该项目有望在2026年上半年进 入投产状态。到2027年，公司人造石墨负极材料有效产能将超过50万吨。 （ 来源： 人民财讯） | 往 | 期 | 回 顾 | | --- | --- | --- | | 01 | ｜ | 七大电芯厂业绩PK！ | | 02 | ｜ | 注资20个亿！宁德时代新设子公司 | | 03 | ｜ | 巨头退场！松下宣布关闭光伏业务部门 | | | ｜ 举办 | 2025起点轻型动力电池及两轮车换电大会7月10-11日无锡 | | 04 | | | ...

2. 战略布局海外产能建设，提升供应能力，与海外大客户合作进一步深化。公司持续强化海外生产供应 能力建设，其中1）美国子公司顺利通过三方体系认证和客户二方认证，实现对美国订单的顺利承接， 2）泰国子公司建立了内窥镜和光源模组生产能力，实现公司绝大多数对美销售产品的生产，可与美国 子公司、国内工厂实现内部调节和生产协同，并灵活应对中美贸易政策变化。此外，公司已与美国客户 开展下一代系统的协助研发，产品覆盖范围将从普外科扩展到运动医学、妇科、泌尿、关节以及头颈外 科等科室，持续深化与海外大客户的合作。 盈利预测：我们预计公司2025-2027 年营收分别为5.52、6.76、8.12 亿元，同比增速分别为24.64%、 22.54%、20.00%，归母净利润分别为1.87、2.34、2.83 亿元，同比增速分别为38.00%、25.50%、 20.92%，对应当前股价PE 分别为22、18、15 倍，维持"推荐"评级。 风险提示：研发及上市进度不及预期，市场竞争加剧，行业政策变动风险，市场拓展不及预期，海外订 单恢复不及预期等。 事件： 公司发布2024 年度及2025 年一季度报告，2024 年实现营业收入4. ...

公司研究 25Q1 业绩同环比大幅提升，新项目建设稳步推进 ——先达股份（603086.SH）2024 年年报及 2025 年一季报点评 要点 事件：公司发布 2024 年年度报告及 2025 年一季报。24 年公司实现营业收入 24.19 亿元，同比-1.68%，实现归母净利润-0.26 亿元，同比增加 0.78 亿元。25Q1 公司实现营业收入 5.43 亿元，同比+10.78%，环比+3.10%；实现归母净利润 0.22 亿元，同比增加 3.55 亿元，环比增加 5.38 亿元。 2025 年 4 月 30 日 新项目建设稳步推进，海外市场核心产品销量大幅增长。24 年，公司的辽宁先 达生产基地一期至五期项目已成功投产并实现产值，进一步巩固了公司在核心原 药产能方面的优势。同时，公司新建"年产 1800 吨农药原药、年产 500 吨安全 剂项目"及"年产 20000 吨自动化综合制剂项目"已完成验收并试生产，重点 布局苯丙草酮、吡唑喹草酯等新产品生产及提升制剂加工能力，以满足国内市场 销售快速增长的需求。同时，24 年，公司海外市场核心产品销量实现大幅增长， 烯草酮制剂出口量同比增长 88%。烯草酮系列 ...

赣锋锂业（ [Table_StockNameRptType] 002460） 公司点评 全球布局提升自给率，产能建设持续推进 | | | | [Table_BaseData] 收盘价（元） | 30.18 | | --- | --- | | 近 12 个月最高/最低（元） | 45.30/24.90 | | 总股本（百万股） | 2,017 | | 流通股本（百万股） | 1,209 | | 流通股比例（%） | 59.92 | | 总市值（亿元） | 609 | | 流通市值（亿元） | 365 | [公司价格与沪深 Table_Chart] 300 走势比较 -36% -17% 2% 21% 40% 4/24 7/24 10/24 1/25 赣锋锂业 沪深300 [Table_Author] 分析师：许勇其 执业证书号：S0010522080002 邮箱：xuqy@hazq.com 分析师：牛义杰 执业证书号：S0010524050005 邮箱：niuyj@hazq.com 1、《赣锋锂业 24 年 Q3 点评： Q3 业绩超预期，一体化布局持续推进》 2024-11-6 主要观点： ⚫[Table_Su ...

Core Viewpoint - The company reported a decline in revenue and net profit for Q1 2025, primarily due to falling coal prices, despite stable production and sales volumes [1][2]. Revenue and Profit Summary - In Q1 2025, the company achieved operating revenue of 38.39 billion yuan, a year-on-year decrease of 15.4% [1] - The net profit attributable to shareholders was 3.98 billion yuan, down 20.0% year-on-year [1] - The net profit after deducting non-recurring items was 3.94 billion yuan, a decline of 19.4% year-on-year [1] Coal Production and Sales - The company sold 64.14 million tons of commodity coal in Q1 2025, a slight increase of 0.4% year-on-year [1] - Self-produced commodity coal sales reached 32.68 million tons, up 1.1% year-on-year [1] - The average selling price of coal was 487 yuan/ton, down 17.0% year-on-year, while the average price for self-produced coal was 492 yuan/ton, down 17.7% year-on-year [1][2] Cost and Profitability - The cost of self-produced commodity coal was 270 yuan/ton, a decrease of 7.3% year-on-year [2] - The gross profit per ton of self-produced coal was 222 yuan, down 27.6% year-on-year [2] - Overall coal revenue was 31.25 billion yuan, a decline of 16.6% year-on-year, with operating costs at 23.80 billion yuan, down 13.0% year-on-year [2] Chemical Products Performance - The company sold 355,000 tons of olefins in Q1 2025, a decrease of 4.8% year-on-year, with an average price of 6,876 yuan/ton, up 0.4% year-on-year [2] - Urea sales reached 600,000 tons, an increase of 8.9% year-on-year, with an average price of 1,702 yuan/ton, down 23.9% year-on-year [2] - Methanol sales were 529,000 tons, up 33.6% year-on-year, with an average price of 1,794 yuan/ton, up 7.1% year-on-year, leading to a turnaround in profitability [2] New Capacity and Projects - The company is advancing coal, electricity, and new energy projects, including a stable release of production capacity from the Dahuize coal mine and the upcoming launch of a 400,000-ton/year project [3] - The company is also constructing a 900,000-ton/year polyolefin project and accelerating the development of various renewable energy projects [3] Dividend and Profit Forecast - The company plans to distribute a cash dividend of 0.258 yuan per share for the end of 2024, with a total dividend payout exceeding 30% [3] - Revenue projections for 2025-2027 are 162.1 billion yuan, 156.5 billion yuan, and 156.0 billion yuan, respectively, with a forecasted net profit of 15 billion yuan, 14.7 billion yuan, and 14.6 billion yuan [3]

Core Viewpoint - The company reported a revenue of 362.01 billion yuan for 2024, a year-on-year decrease of 9.7%, while achieving a net profit attributable to shareholders of 50.75 billion yuan, a year-on-year increase of 15.0% [1] Financial Performance - In Q4 2024, the company achieved a revenue of 102.97 billion yuan, a year-on-year decrease of 3.1%, but a quarter-on-quarter increase of 11.6%. The net profit attributable to shareholders was 14.74 billion yuan, a year-on-year increase of 13.6% and a quarter-on-quarter increase of 12.2% [1] - For Q1 2025, the company reported a revenue of 84.71 billion yuan, a year-on-year increase of 6.2%, but a quarter-on-quarter decrease of 17.7%. The net profit attributable to shareholders was 13.96 billion yuan, a year-on-year increase of 32.9% [1] Profitability and Cost Control - The company maintained stable profitability with a gross profit margin of 24.4% and a net profit margin of 14.9% for 2024, reflecting year-on-year increases of 1.5 percentage points and 3.3 percentage points, respectively [2] - In Q1 2025, the gross profit margin was 24.4%, while the net profit margin increased to 17.5%, showing a year-on-year increase of 3.5 percentage points [2] - The company effectively controlled its expense ratios, with sales, management, R&D, and financial expense ratios for 2024 at 1.0%, 2.7%, 5.1%, and -1.1%, respectively [2] Market Position and Product Innovation - The company maintained a leading market share with a sales volume of 381 GWh for power battery systems in 2024, a year-on-year increase of 18.85%, achieving a global market share of 37.9% [3] - The sales volume for energy storage battery systems reached 93 GWh, a year-on-year increase of 34.32%, with a global market share of 36.5% [3] - The company launched innovative products such as the Tianheng energy storage system and the Shenxing Plus battery, enhancing its competitive edge [3] Capacity Expansion and International Development - The company has a current capacity of approximately 676 GWh, with an additional 219 GWh under construction [3] - The German factory's capacity is gradually increasing, and the company has received dual certification from the Volkswagen Group for module testing and cell testing laboratories [3] - Ongoing projects in Hungary, a joint venture factory in Spain with Stellantis, and the Indonesian battery supply chain project are expected to enhance product profitability [3] Earnings Forecast and Investment Recommendation - The company is projected to have EPS of 14.27 yuan, 17.89 yuan, and 22.34 yuan for 2025-2027, with corresponding PE ratios of 16x, 13x, and 10x [4] - The steady release of overseas capacity and the continuous launch of new products are expected to lead to a higher dividend payout ratio, maintaining a "buy" rating [4]

2025 年 4 月 29 日 当前价：16.43 元 作者 分析师：赵乃迪 执业证书编号：S0930517050005 010-57378026 zhaond@ebscn.com 分析师：周家诺 执业证书编号：S0930523070007 021-52523675 zhoujianuo@ebscn.com 公司研究 资产减值影响 24Q4 业绩，龙南基地项目陆续投产 ——广信材料（300537.SZ）2024 年报及 2025 一季报点评 增持（维持） 市场数据 | 总股本(亿股) | 2.00 | | --- | --- | | 总市值(亿元)： | 32.93 | | 一年最低/最高(元)： | 14.00/24.83 | | 近 3 月换手率： | 318.54% | 股价相对走势 -10% 11% 33% 54% 75% 04/24 07/24 10/24 01/25 广信材料 沪深300 收益表现 | % | 1M | 3M | 1Y | | --- | --- | --- | --- | | 相对 | -7.50 | -1.26 | 4.03 | | 绝对 | -10.22 | -1.62 | ...

上 市 公 司 公 司 研 究 / 公 司 点 评 2025 年 04 月 29 日 伟测科技 (688372) 报告原因：有业绩公布需要点评 买入（维持） | 市场数据： | 2025 年 04 月 28 日 | | --- | --- | | 收盘价（元） | 79.92 | | 一年内最高/最低（元） | 99.99/33.97 | | 市净率 | 3.6 | | 息率（分红/股价） | 0.40 | | 流通 A 股市值（百万元） | 6,289 | | 上证指数/深证成指 | 3,288.41/9,855.20 | | 注："息率"以最近一年已公布分红计算 | | | 基础数据: | 2025 年 03 月 31 日 | | --- | --- | | 每股净资产（元） | 23.33 | | 资产负债率% | 48.67 | | 总股本/流通 A 股（百万） | 114/79 | | 流通 B 股/H 股（百万） | -/- | 一年内股价与大盘对比走势： 04-29 05-29 06-29 07-29 08-29 09-29 10-29 11-29 12-29 01-29 02-28 03-31 ...

新产品、新产能、新市场有序拓展，筑牢自身发展基础1）新产品：截至24 年底，公司安全自毁留置 针、双头安全自锁胰岛素笔针头、动物疫苗连续计数注射器、低残留注射器等产品已完成研发并投入生 产；预充式导管冲洗器、营养喂食注射器、精密过滤盒等产品已处于产品试验及生产流程完善阶段。 2）新产能：截至24 年底，公司位于澄鹿路的二期厂房项目已部分完工，海外产能建设正持续推进。 3）新市场：截至24年底，公司多款产品已获得加拿大、沙特等国的产品注册证，新兴市场开拓工作有 序推进。我们看好公司通过新产品、新产能及新市场开发积极收获业绩增量并进一步提升整体抗风险能 力，夯实长期发展基础。 盈利预测与估值 综合考虑公司新产品、新市场开发对于收入增速的拉动及强化产品推广对于销售费用率的影响，我们调 整25-27 年归母净利至0.74/0.83/0.93 亿元（相比25/26 年前值调整-9%/-14%）。公司为注射穿刺器械领 域领军者，产品品类丰富且客户持续拓展，给予公司25 年34x PE （可比公司Wind 一致预期均值 32x），调整目标价至20.59 元（前值18.62 元，对应24 年33x PE）。 公司1Q25 收 ...